Table 1. Clinical characteristics of patient cohort with RCC (n=275).
| Parameter | Absolute | Proportion |
|---|---|---|
| Age, years mean (range) |
61.0 (30-86) | - |
| Follow-up, months median (range) |
91.0 (1-159) | - |
| Status to the end of follow-up | ||
| alive | 192 | 69.8% |
| dead | 83 | 30.2% |
| Sex: | ||
| male | 187 | 68.0% |
| female | 88 | 32.0% |
| Histological subtype: | ||
| clear cell | 230 | 83.6% |
| papillary | 35 | 12.7% |
| chromophobe | 10 | 3.7% |
| pT-Stage (TNM 2002): | ||
| pT1a | 100 | 36.4% |
| pT1b | 66 | 24.0% |
| pT2 | 21 | 7.6% |
| pT3a | 32 | 11.6% |
| pT3b | 50 | 18.2% |
| pT3c | 4 | 1.5% |
| pT4 | 2 | 0.7% |
| WHO/ISUP grade: | ||
| 1 | 48 | 17.5% |
| 2 | 154 | 56.0% |
| 3 | 47 | 17.1% |
| 4 | 16 | 5.8% |
| N/Aa | 10 | 3.6% |
| pN-Stage: | ||
| N0 | 146 | 53.1% |
| N+ | 16 | 5.8% |
| Nx | 113 | 41.1% |
| Lymphadenectomy | ||
| Yes | 150 | 54.4% |
| No | 125 | 45.6% |
| M-Stage (clinical) | ||
| M0 | 245 | 89.1% |
| M1 synchronic | 19 | 6.9% |
| M1 asynchronic | 11 | 4.0% |
| R-status | ||
| R0 | 250 | 90.9% |
| R1 | 10 | 3.6% |
| R2 | 4 | 1.5% |
| not available | 11 | 4.0% |
| Adrenalectomy | ||
| Yes | 174 | 63.3% |
| No | 101 | 36.7% |
| ECOG performance status | ||
| 0 | 189 | 68.8% |
| 1 | 79 | 28.7% |
| 2 | 7 | 2.5% |
Comments: a - No grading for chromophobe subtype